VERITAS-Pro

A new measure of adherence to prophylactic regimens in haemophilia

N. A. Duncan, William Kronenberger, C. Roberson, A. Shapiro

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Prophylactic treatment is recommended for severe haemophilia. Non-adherence to a prophylactic regimen can limit treatment effectiveness and compromise outcomes. The aim of this study is to validate a new prophylactic treatment adherence scale entitled Validated Hemophilia Regimen Treatment Adherence Scale - Prophylaxis (VERITAS-Pro), a self-/parent-report questionnaire consisting of 24 questions on six (four-item) subscales (Time, Dose, Plan, Remember, Skip, Communicate) that takes approximately 10 min to complete and is currently available in English only. Participants were recruited to complete the VERITAS-Pro for validation and reliability analysis; and observers were recruited for inter-rater reliability analysis. Validation measures included subjective adherence ratings from participants and providers and the total number of recommended infusions administered as obtained from infusion logs. Data were evaluated for the entire sample and for parent-report and self-report subsamples. The study sample included 67 males, 53 (79.1%) diagnosed with severe FVIII deficiency. Internal consistency for the total VERITAS-Pro score and all subscales was good to excellent; test-retest reliability correlations were very strong. Validation measures were strongly correlated with VERITAS-Pro scores. The VERITAS-Pro is a reliable and valid measure of adherence to prophylactic treatment of haemophilia. The VERITAS-Pro has greater utility than a global or informal rating of adherence because it represents a quantified and validated measure of adherence from the patient's perspective and it divides adherence into specific areas, allowing insight into particular issues underlying non-adherence. This tool may increase sensitivity to adherence problems and allow more targeted interventions to enhance adherence.

Original languageEnglish
Pages (from-to)247-255
Number of pages9
JournalHaemophilia
Volume16
Issue number2
DOIs
StatePublished - Mar 2010

Fingerprint

Hemophilia A
Self Report
Patient Compliance
Reproducibility of Results

Keywords

  • Prophylaxis
  • Reliability
  • Scale development
  • Severe haemophilia
  • Treatment adherence
  • Validity

ASJC Scopus subject areas

  • Hematology
  • Genetics(clinical)

Cite this

VERITAS-Pro : A new measure of adherence to prophylactic regimens in haemophilia. / Duncan, N. A.; Kronenberger, William; Roberson, C.; Shapiro, A.

In: Haemophilia, Vol. 16, No. 2, 03.2010, p. 247-255.

Research output: Contribution to journalArticle

Duncan, N. A. ; Kronenberger, William ; Roberson, C. ; Shapiro, A. / VERITAS-Pro : A new measure of adherence to prophylactic regimens in haemophilia. In: Haemophilia. 2010 ; Vol. 16, No. 2. pp. 247-255.
@article{643a39a8302f4a36a8c86d900e31afc7,
title = "VERITAS-Pro: A new measure of adherence to prophylactic regimens in haemophilia",
abstract = "Prophylactic treatment is recommended for severe haemophilia. Non-adherence to a prophylactic regimen can limit treatment effectiveness and compromise outcomes. The aim of this study is to validate a new prophylactic treatment adherence scale entitled Validated Hemophilia Regimen Treatment Adherence Scale - Prophylaxis (VERITAS-Pro), a self-/parent-report questionnaire consisting of 24 questions on six (four-item) subscales (Time, Dose, Plan, Remember, Skip, Communicate) that takes approximately 10 min to complete and is currently available in English only. Participants were recruited to complete the VERITAS-Pro for validation and reliability analysis; and observers were recruited for inter-rater reliability analysis. Validation measures included subjective adherence ratings from participants and providers and the total number of recommended infusions administered as obtained from infusion logs. Data were evaluated for the entire sample and for parent-report and self-report subsamples. The study sample included 67 males, 53 (79.1{\%}) diagnosed with severe FVIII deficiency. Internal consistency for the total VERITAS-Pro score and all subscales was good to excellent; test-retest reliability correlations were very strong. Validation measures were strongly correlated with VERITAS-Pro scores. The VERITAS-Pro is a reliable and valid measure of adherence to prophylactic treatment of haemophilia. The VERITAS-Pro has greater utility than a global or informal rating of adherence because it represents a quantified and validated measure of adherence from the patient's perspective and it divides adherence into specific areas, allowing insight into particular issues underlying non-adherence. This tool may increase sensitivity to adherence problems and allow more targeted interventions to enhance adherence.",
keywords = "Prophylaxis, Reliability, Scale development, Severe haemophilia, Treatment adherence, Validity",
author = "Duncan, {N. A.} and William Kronenberger and C. Roberson and A. Shapiro",
year = "2010",
month = "3",
doi = "10.1111/j.1365-2516.2009.02129.x",
language = "English",
volume = "16",
pages = "247--255",
journal = "Haemophilia",
issn = "1351-8216",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - VERITAS-Pro

T2 - A new measure of adherence to prophylactic regimens in haemophilia

AU - Duncan, N. A.

AU - Kronenberger, William

AU - Roberson, C.

AU - Shapiro, A.

PY - 2010/3

Y1 - 2010/3

N2 - Prophylactic treatment is recommended for severe haemophilia. Non-adherence to a prophylactic regimen can limit treatment effectiveness and compromise outcomes. The aim of this study is to validate a new prophylactic treatment adherence scale entitled Validated Hemophilia Regimen Treatment Adherence Scale - Prophylaxis (VERITAS-Pro), a self-/parent-report questionnaire consisting of 24 questions on six (four-item) subscales (Time, Dose, Plan, Remember, Skip, Communicate) that takes approximately 10 min to complete and is currently available in English only. Participants were recruited to complete the VERITAS-Pro for validation and reliability analysis; and observers were recruited for inter-rater reliability analysis. Validation measures included subjective adherence ratings from participants and providers and the total number of recommended infusions administered as obtained from infusion logs. Data were evaluated for the entire sample and for parent-report and self-report subsamples. The study sample included 67 males, 53 (79.1%) diagnosed with severe FVIII deficiency. Internal consistency for the total VERITAS-Pro score and all subscales was good to excellent; test-retest reliability correlations were very strong. Validation measures were strongly correlated with VERITAS-Pro scores. The VERITAS-Pro is a reliable and valid measure of adherence to prophylactic treatment of haemophilia. The VERITAS-Pro has greater utility than a global or informal rating of adherence because it represents a quantified and validated measure of adherence from the patient's perspective and it divides adherence into specific areas, allowing insight into particular issues underlying non-adherence. This tool may increase sensitivity to adherence problems and allow more targeted interventions to enhance adherence.

AB - Prophylactic treatment is recommended for severe haemophilia. Non-adherence to a prophylactic regimen can limit treatment effectiveness and compromise outcomes. The aim of this study is to validate a new prophylactic treatment adherence scale entitled Validated Hemophilia Regimen Treatment Adherence Scale - Prophylaxis (VERITAS-Pro), a self-/parent-report questionnaire consisting of 24 questions on six (four-item) subscales (Time, Dose, Plan, Remember, Skip, Communicate) that takes approximately 10 min to complete and is currently available in English only. Participants were recruited to complete the VERITAS-Pro for validation and reliability analysis; and observers were recruited for inter-rater reliability analysis. Validation measures included subjective adherence ratings from participants and providers and the total number of recommended infusions administered as obtained from infusion logs. Data were evaluated for the entire sample and for parent-report and self-report subsamples. The study sample included 67 males, 53 (79.1%) diagnosed with severe FVIII deficiency. Internal consistency for the total VERITAS-Pro score and all subscales was good to excellent; test-retest reliability correlations were very strong. Validation measures were strongly correlated with VERITAS-Pro scores. The VERITAS-Pro is a reliable and valid measure of adherence to prophylactic treatment of haemophilia. The VERITAS-Pro has greater utility than a global or informal rating of adherence because it represents a quantified and validated measure of adherence from the patient's perspective and it divides adherence into specific areas, allowing insight into particular issues underlying non-adherence. This tool may increase sensitivity to adherence problems and allow more targeted interventions to enhance adherence.

KW - Prophylaxis

KW - Reliability

KW - Scale development

KW - Severe haemophilia

KW - Treatment adherence

KW - Validity

UR - http://www.scopus.com/inward/record.url?scp=77950240992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950240992&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2516.2009.02129.x

DO - 10.1111/j.1365-2516.2009.02129.x

M3 - Article

VL - 16

SP - 247

EP - 255

JO - Haemophilia

JF - Haemophilia

SN - 1351-8216

IS - 2

ER -